By injecting a specific, measured quantity of stem cells/biologics – primarily amniotic stem cells, balanced with specific elements to maximize penile rejuvenation, patients who have failed traditional oral or injection therapy are experiencing the benefits of regenerative technology.
The appropriate patients for treatment include any patient with Erectile Dysfunction or Peyronie’s Disease and those who have failed other therapies. Stem cell/biologics therapy is offered in an office setting, so no surgery or hospital stay is required.
Patients are recommended to undergo 2 injections of stem cell/biologic therapy into the penis. Injections will be conducted once a month for a period of 2 months. Follow ups will be conducted at 1 week post injection and every 3 months post treatment for the first year.
Results vary from patient to patient. However, some patients have seen results as early as 1-2 weeks postinjection. Patients have also noted improved morning erections, better erections with and without a PDE-5 inhibitor, and decrease in degree of curvature, etc.
• Infection, pain, bleeding, and swelling at the injection site
• Worsening of Erectile Dysfunction and/or Peyronie’s Disease
• Blood Borne Pathogen
Stem cell /Biologic Therapy is experimental therapy not currently covered by health insurance companies. Cost varies depending on number and type of injections.
* This web site is a repository of publicly available information, and is not intended to form a physician-patient relationship with any individual. Individual urologic conditions, treatment and recovery times may vary. The information presented on this web site is not intended to take the place of your personal physician’s advice and is not intended to diagnose, treat, cure or prevent any disease. Discuss this information with your own physician or healthcare provider to determine what is right for you. The information contained herein is presented in summary form only and intended to provide broad consumer understanding and knowledge. Each patient’s experience with procedures described herein will differ.
**Statements, treatments and other information on this web site have not been evaluated by the US Food & Drug Administration. The stem cell protocols we offer, using autologous bone marrow-, autologous adipose- and allogeneic human umbilical cord-derived stem cells amniotic, are not approved in the United States as treatments, therapies, drugs, new drugs or investigational drugs. All information on this web site is provided for informational purposes only. We do not claim that our treatment protocols are approved by the US FDA or proven to be effective in the United States for any condition that appears on this site or for any other condition. There could be significant and unknown risks associated with adult stem cell treatments, as long-term studies have not been performed. Very few, randomized clinical trials of adult stem cells have been performed, therefore no guarantee of safety or effectiveness is made or implied.
***The opinions expressed in patient testimonials are by patients only; they are not qualified medical professionals. These opinions should not be relied upon as, or in place of, the medical advice of a licensed doctor or other health care provider.